NextSourceCS Acquires Amatheon Compounding Services in an Effort To Help Alleviate The Absence of Critical Discontinued Drugs in the Veterinary Industry

MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Compounding Services (NSCS) is a leading marketing company focused on providing referral compounding services of unavailable or discontinued pharmaceuticals for the veterinary industry.  NSCS, formally Amatheon Compounding Referral Services, has been strategically positioned to continue marketing a portfolio of high quality pharmaceuticals that comply with USP-797 quality and efficacy standards.  NSCS services over 40,000 veterinary practices Nationwide.

As a result of the Elspar® product (Lundbeck) discontinuation in 2012, the veterinary oncology community has faced many challenges in providing patients with consistent high quality chemotherapy treatments.  Due to the growing concern among veterinary oncologists, NSCS contracted a third-party analytics laboratory to conduct potency and sterility tests on random batches of all competing compounded L-Asparaginase.  Using the FDA approved parent drug (Elspar®), the test results showed that the competing product's potency ranged between 48% to 53%.  Whereas the NSCS / QmedRx product comparatively yielded a 96% potency test result (exceeding USP-797 guidelines).

"Quality and consistency are critically important to superior patient care," said Robert DiCrisci, President and CEO of NextSource Compounding Services. "Our goal is to provide veterinary professionals with peace of mind when using any our compounded Oncology medications."

In related news, the compounding industry has been scrutinized due to pharmacies not maintaining state and federal guidelines.  In recent years, a Massachusetts pharmacy dispensed medications that did not meet the sterility and potency guidelines leading to over 700 serious infections and more than 60 patient fatalities, many related to the meningitis bacterial infection.

As an NSCS partner, QmedRx (PCAB Accredited Pharmacy) follows strict USP-795 and USP-797 standards of pharmacy practices and procedures, making their compounded L-Asparaginase the highest quality product in the market today.  All compounding is performed in a Class 100 sterile hood and clean room and a state of the art Quantos Dosing Machine is utilized to weigh the exact dosing of each vial.  The test results from each lot are readily available for healthcare professionals to verify and validate at www.nextsourcecs.com.

Currently, NSCS compounded medications can be ordered by contacting customer service at 866-924-9997.  An online electronic prescription script ordering system will be available to provide further ordering convenience.

About NextSource Compounding Services: Formally AmatheonCS, NSCS is a marketing and referral company located in Miami, FL.  NSCS is committed to raising the veterinary industry standards in compounding by providing the highest quality specialty medications in the market.  QmedRx, is an industry leading Florida based specialty compounding pharmacy established in 1990 and licensed in 48 states Nationwide.   QmedRx is an ACHC™ and PCAB accredited pharmacy that compounds quality medications under ISO 5 guidelines to ensure patient safety and product efficacy.  For more information, please visit:   www.qmedrx.com

SOURCE NextSource Compounding Services